erlotinib hydrochloride has been researched along with Carcinoma, Mucoepidermoid in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Chen, Z; Kaye, FJ; Lu, J; Ni, W; Wu, L; Yang, R; Yu, M; Zhou, X | 1 |
Dahse, R; Kosmehl, H | 1 |
Chan, AB; Lam, KC; Lee, KW; Lo, AW | 1 |
3 other study(ies) available for erlotinib hydrochloride and Carcinoma, Mucoepidermoid
Article | Year |
---|---|
Targeting Notch and EGFR signaling in human mucoepidermoid carcinoma.
Topics: Animals; Carcinoma, Mucoepidermoid; Cell Proliferation; ErbB Receptors; Erlotinib Hydrochloride; Heterografts; Humans; Mice; Molecular Targeted Therapy; Neoplastic Stem Cells; Oncogene Proteins, Fusion; Receptors, Notch; Salivary Gland Neoplasms; Signal Transduction; Trans-Activators; Transcription Factors; Translocation, Genetic | 2021 |
Detection of drug-sensitizing EGFR exon 19 deletion mutations in salivary gland carcinoma.
Topics: Aged; Carcinoma, Adenoid Cystic; Carcinoma, Mucoepidermoid; DNA, Neoplasm; Drug Resistance; ErbB Receptors; Erlotinib Hydrochloride; Exons; Female; Gefitinib; Humans; Male; Middle Aged; Mutation; Parotid Neoplasms; Protein Kinase Inhibitors; Quinazolines | 2008 |
Erlotinib in metastatic bronchopulmonary mucoepidermoid carcinoma.
Topics: Adult; Carcinoma, Mucoepidermoid; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Male; Mediastinal Neoplasms; Pleural Neoplasms; Protein Kinase Inhibitors; Quinazolines; Splenic Neoplasms | 2011 |